Flagship on center stage: Axcella’s new CMO likens the biotech to ‘professional sports team’; Life after the FDA takes shape for Stephen Hahn as a chief executive
Margaret Koziel has bounced back and forth between academia and biotech throughout her career — and after 25 years, she has landed her first position as part of a biotech’s top brass.
Koziel joined Axcella Therapeutics — founded by Flagship’s Noubar Afeyan, Geoffrey von Maltzahn and David Berry as Axcella Health — in 2019, and as of Monday, she is now in the C-suite as the biotech’s new CMO.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.